159 related articles for article (PubMed ID: 36074674)
41. The immunoexpression of p53 and Snail in endometrioid endometrial carcinomas.
Dragomirescu M; Stepan AE; Mărgăritescu C; Simionescu CE
Rom J Morphol Embryol; 2018; 59(1):131-137. PubMed ID: 29940620
[TBL] [Abstract][Full Text] [Related]
42. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
43. Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer.
Kudela M; Pilka R; Lubusky M; Hejtmanek P; Dzubak P; Brychtova S
Eur J Gynaecol Oncol; 2012; 33(2):159-63. PubMed ID: 22611955
[TBL] [Abstract][Full Text] [Related]
44. Endometrial carcinomas: correlation between ER, PR, Ki67 status and histopathological prognostic parameters.
Stoian SC; Simionescu C; Mărgăritescu C; Stepan A; Nurciu M
Rom J Morphol Embryol; 2011; 52(2):631-6. PubMed ID: 21655654
[TBL] [Abstract][Full Text] [Related]
45. Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma.
Park JY; Hong DG; Chong GO; Park JY
Pathol Oncol Res; 2019 Apr; 25(2):723-730. PubMed ID: 30604272
[TBL] [Abstract][Full Text] [Related]
46. Distribution of estrogen and progesterone receptors isoforms in endometrial cancer.
Kreizman-Shefer H; Pricop J; Goldman S; Elmalah I; Shalev E
Diagn Pathol; 2014 Mar; 9():77. PubMed ID: 24684970
[TBL] [Abstract][Full Text] [Related]
47. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
48. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
49. Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study.
Zannoni GF; Vellone VG; Arena V; Prisco MG; Scambia G; Carbone A; Gallo D
Virchows Arch; 2010 Jul; 457(1):27-34. PubMed ID: 20552366
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
51. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
52. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
53. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
55. Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.
Reijnen C; Küsters-Vandevelde HVN; Abbink K; Zusterzeel PLM; van Herwaarden AE; van der Laak JAWM; Massuger LFAG; Snijders MPLM; Pijnenborg JMA; Bulten J
Hum Pathol; 2019 Mar; 85():119-127. PubMed ID: 30428390
[TBL] [Abstract][Full Text] [Related]
56. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
57. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
58. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors.
Pizer ES; Lax SF; Kuhajda FP; Pasternack GR; Kurman RJ
Cancer; 1998 Aug; 83(3):528-37. PubMed ID: 9690546
[TBL] [Abstract][Full Text] [Related]
59. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
60. Endometrial adenocarcinoma: beliefs and scepticism.
Sivridis E; Giatromanolaki A
Int J Surg Pathol; 2004 Apr; 12(2):99-105. PubMed ID: 15173914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]